Physician
Infectious Disease
Dr. Kenneth J. Tack, MD
|
|
Give Review
Kenneth Tack works in the field of Infectious Disease. He graduated from University of Michigan Medical School. Kenneth J. Tack is also a published physician. He has 33 publication published. The most recent publication is: Five-day cefdinir treatment for streptococcal pharyngitis. Cefdinir Pharyngitis Study Group.
Publications
- Pharmacokinetics and Safety of Single and Multiple Doses of ACHN-490 Injection Administered Intravenously in Healthy Subjects.
- Combined retrospective analysis of seven phase II and III trials of the efficacy of linezolid in the treatment of pneumonia caused by multidrug-resistant Streptococcus...
- Complicated skin and skin-structure infections and catheter-related bloodstream infections: noninferiority of linezolid in a phase 3 study.
- Efficacy and safety of linezolid compared with vancomycin in a randomized, double-blind study of febrile neutropenic patients with cancer.
- Cefpodoxime proxetil in the treatment of skin and soft tissue infections.
- Comparative safety and efficacy of cefdinir vs amoxicillin/clavulanate for treatment of suppurative acute otitis media in children.
- A comparison of a five-day regimen of cefdinir with a seven-day regimen of loracarbef for the treatment of acute exacerbations of chronic bronchitis.
- Comparison of a 5 day regimen of cefdinir with a 10 day regimen of cefprozil for treatment of acute exacerbations of chronic bronchitis.
- Pharmacokinetics of ofloxacin in healthy subjects and patients with varying degrees of renal impairment.
- Comparison of cefdinir and penicillin for the treatment of pediatric streptococcal pharyngitis.
- Effects of magnesium-aluminum hydroxide and calcium carbonate antacids on bioavailability of ofloxacin.
- Inhibition of theophylline clearance by coadministered ofloxacin without alteration of theophylline effects.
- Accidental overdose of intravenous ofloxacin with benign outcome.
- Safety and pharmacokinetics of single dose intravenous ofloxacin in healthy volunteers.
- International study comparing cefdinir and cefuroxime axetil in the treatment of patients with acute exacerbation of chronic bronchitis.
- Results of a clinical trial of clinafloxacin versus imipenem/cilastatin for intraabdominal infections.
- Open-label, multicentre, emergency-use study of clinafloxacin (CI-960) in the treatment of patients with serious life-threatening infections.
- Study of use of cefdinir versus cephalexin for treatment of skin infections in pediatric patients. The Cefdinir Pediatric Skin Infection Study Group.
- Comparative effectiveness and safety of cefdinir and amoxicillin-clavulanate in treatment of acute community-acquired bacterial sinusitis. Cefdinir Sinusitis Study Group.
- Five-day cefdinir treatment for streptococcal pharyngitis. Cefdinir Pharyngitis Study Group.
- Efficacy and safety of cefdinir in the treatment of patients with acute bronchitis. The Cefdinir Bronchitis Study Group.
- Cefdinir versus cefaclor in the treatment of uncomplicated urinary tract infection.
- Comparison of cefdinir and cefaclor in treatment of community-acquired pneumonia.
- Comparison of cefdinir and penicillin for the treatment of streptococcal pharyngitis. Cefdinir Pharyngitis Study Group.
- Clinafloxacin monotherapy (CI-960) versus ceftazidime plus amikacin for empirical treatment of febrile neutropenic cancer patients.
- Cefdinir versus cephalexin for the treatment of skin and skin-structure infections. The Cefdinir Adult Skin Infection Study Group.
- Randomized, double-blind, multicenter trial comparing clinafloxacin with imipenem as empirical monotherapy for febrile granulocytopenic patients.
- A prospective, randomized, multicenter comparative study of clinafloxacin versus a ceftriaxone-based regimen in the treatment of hospitalized patients with community-a...
- Linezolid versus vancomycin for the treatment of infections caused by methicillin-resistant Staphylococcus aureus in Japan.
- Initial clinical experience with clinafloxacin in the treatment of serious infections.
- Clinafloxacin versus piperacillin-tazobactam in treatment of patients with severe skin and soft tissue infections.
- Clinafloxacin for the treatment of bacterial endocarditis.
Schools
University of Mi Med Sch
Doctors Specialties
- Infectious Disease Medicine
- Infectious Disease
Accepted Insurances
Education
-
University of Minnesota at Fairview -
University of Michigan Medical School
Helpful Reviews
Similar Doctors
|
|
Dr. Sarah Cookinham, MD
 This Doctor is OpenDoctor Recommended.
|